Core Laboratories N.V.CLBNYSE
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
36.86%
↓ 58% below average
Average (39q)
87.91%
Historical baseline
Range
High:3080.05%
Low:-617.56%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 36.86% |
| Q2 2025 | 246.19% |
| Q1 2025 | -68.84% |
| Q4 2024 | -28.42% |
| Q3 2024 | 23.71% |
| Q2 2024 | 86.77% |
| Q1 2024 | -41.22% |
| Q4 2023 | -0.62% |
| Q3 2023 | -22.40% |
| Q2 2023 | 191.71% |
| Q1 2023 | -58.50% |
| Q4 2022 | 6.64% |
| Q3 2022 | 25.69% |
| Q2 2022 | 3080.05% |
| Q1 2022 | -102.75% |
| Q4 2021 | 113.86% |
| Q3 2021 | -48.13% |
| Q2 2021 | 10.14% |
| Q1 2021 | -50.34% |
| Q4 2020 | 106.55% |
| Q3 2020 | 541.41% |
| Q2 2020 | 97.64% |
| Q1 2020 | -617.56% |
| Q4 2019 | -32.53% |
| Q3 2019 | 11.42% |
| Q2 2019 | 70.63% |
| Q1 2019 | -8.70% |
| Q4 2018 | -48.46% |
| Q3 2018 | 4.28% |
| Q2 2018 | 3.51% |
| Q1 2018 | -0.19% |
| Q4 2017 | 17.84% |
| Q3 2017 | -6.57% |
| Q2 2017 | 26.87% |
| Q1 2017 | 7.69% |
| Q4 2016 | 0.17% |
| Q3 2016 | 6.23% |
| Q2 2016 | -11.83% |
| Q1 2016 | -2.97% |
| Q4 2015 | -49.50% |